2FNT

Crystal structure of a drug-resistant (V82A) inactive (D25N) HIV-1 protease complexed with AP2V variant of HIV-1 NC-p1 substrate.

2FNT の概要

• エントリーDOI: 10.2210/pdb2fnt/pdb
• 関連するPDBエントリー: 1TSQ 2FNS
• 分子名称: protease, NC-p1 substrate PEPTIDE, ACETATE ION, ... (5 entities in total)
• 機能のキーワード: structural intermediate, substrate recognition, hiv-1 protease, nc-p1 substrate, drug resistance, flap conformation, hydrolase
• 由来する生物種: Human immunodeficiency virus 1; 詳細
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 23482.80

構造登録者

Prabu-Jeyabaln, M.,Nalivaika, E.A.,Schiffer, C.A. (登録日: 2006-01-11, 公開日: 2006-09-05, 最終更新日: 2023-08-30)

主引用文献

Prabu-Jeyabalan, M.,Nalivaika, E.A.,Romano, K.,Schiffer, C.A.
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.
J.Virol., 80:3607-3616, 2006

PubMed Abstract: Human immunodeficiency virus type 1 (HIV-1) protease processes and cleaves the Gag and Gag-Pol polyproteins, allowing viral maturation, and therefore is an important target for antiviral therapy. Ligand binding occurs when the flaps open, allowing access to the active site. This flexibility in flap geometry makes trapping and crystallizing structural intermediates in substrate binding challenging. In this study, we report two crystal structures of two HIV-1 protease variants bound with their corresponding nucleocapsid-p1 variant. One of the flaps in each of these structures exhibits an unusual "intermediate" conformation. Analysis of the flap-intermediate and flap-closed crystal structures reveals that the intermonomer flap movements may be asynchronous and that the flap which wraps over the P3 to P1 (P3-P1) residues of the substrate might close first. This is consistent with our hypothesis that the P3-P1 region is crucial for substrate recognition. The intermediate conformation is conserved in both the wild-type and drug-resistant variants. The structural differences between the variants are evident only when the flaps are closed. Thus, a plausible structural model for the adaptability of HIV-1 protease to recognize substrates in the presence of drug-resistant mutations has been proposed.

PubMed: 16537628
DOI: 10.1128/JVI.80.7.3607-3616.2006

実験手法

X-RAY DIFFRACTION (1.44 Å)